Tikcro Technologies Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.13 |
Market Cap |
$2.27 M |
Shares Outstanding |
8.9 M |
Public Float |
3.42 M |
Address |
Kiryat Weizmann Science Park Ness Ziona TA 7403630 Israel |
Employees | - |
Website | http://www.tikcro.com |
Updated | 07/08/2019 |
Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. |